Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Halberd Corp
(OP:
HALB
)
0.0088
UNCHANGED
Streaming Delayed Price
Updated: 3:53 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Halberd Corp
< Previous
1
2
3
4
5
Next >
Halberd CEO Mid-Quarter Update
May 31, 2023
Via
ACCESSWIRE
Halberd Initial Preclinical Testing Phase at Mississippi State University (MSU) Complete
May 23, 2023
Via
ACCESSWIRE
The Street Reports Podcast Hosts Halberd Corp (HALB), Houston Natural Resources (HNRC), Marketing Worldwide (MWWC), Defense Technologies (DTII), PlantX Life (PLTXF) (VEGA.C)
May 12, 2023
Via
AB Newswire
Halberd Pre-Clinical Test Protocol Approved
May 09, 2023
Via
ACCESSWIRE
Halberd (HALB) Pursuing a Nasal Spray to Counteract the Effects of Head Trauma
May 02, 2023
Via
ACCESSWIRE
Halberd Corporation 1Q23 CEO Letter
April 25, 2023
Via
ACCESSWIRE
HALB CEO, CTO and YSU's Dr. Sturrus Discuss CDC, Research Discoveries etc., on "The Street Reports Podcasts" Listen Now!
April 20, 2023
Via
ACCESSWIRE
Halberd & Centers for Disease Control to Meet Regarding Eradication of Antibiotic Resistant Pathogens
March 14, 2023
Via
ACCESSWIRE
Halberd Demonstrates Simultaneous Eradication of Multiple Strains of CDC Provided Antibiotic Resistant Bacteria
February 21, 2023
Via
ACCESSWIRE
Halberd and YSU Interviewed on CBS Affiliate WKBN 5pm News as Research Advances
April 17, 2023
Via
ACCESSWIRE
Halberd Begins Preclinical Testing at Mississippi State University (MSU)
April 11, 2023
Via
ACCESSWIRE
Halberd's Successful Meeting with CDC Leads to Expanded Testing of Antibiotic Resistant Pathogens
April 03, 2023
Via
ACCESSWIRE
Halberd and Mississippi State University (MSU) Sign Agreement to Conduct Pre-Clinical Model Tests of Nasal Spray to Block Negative Effects of Head Trauma
March 30, 2023
Via
ACCESSWIRE
Halberd Eradicates All Strains of Antibiotic Resistant E. Coli Provided by the CDC at Youngstown State University
March 21, 2023
Via
ACCESSWIRE
Halberd Corporation Announces Breakthrough in Candida auris Treatment
February 13, 2023
Via
ACCESSWIRE
Halberd Demonstrates Eradication of CDC Provided Antibiotic Resistant Bacteria
February 08, 2023
Via
ACCESSWIRE
Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma
January 31, 2023
Via
ACCESSWIRE
Halberd Agrees to Animal Testing at Mississippi State University
January 24, 2023
Via
ACCESSWIRE
Halberd Corporation 2022 Year End CEO Letter and 2023 Goals
January 03, 2023
Via
ACCESSWIRE
Halberd Receives Several Strains of Antibiotic Resistant Bacteria from CDC to Test Laser Eradication
December 06, 2022
Via
ACCESSWIRE
"The Street Podcast" Features Halberd's "Groundbreaking" Cancer Treatment Approach. Listen Now!
December 05, 2022
Via
ACCESSWIRE
CORRECTION: Halberd Team Produces Peer Reviewed Article on Antibody Against Covid-19 Omicron Variant
December 01, 2022
Via
ACCESSWIRE
Halberd Team Produces Peer Reviewed Article on Antibody Against Covid-19 Omicron Variant
November 30, 2022
Via
ACCESSWIRE
Halberd Corporation Achieves Groundbreaking Pre-Clinical Endpoint by Eradicating Cancer Disease Antigen Linked to Breast Cancer
November 17, 2022
Via
ACCESSWIRE
Halberd Signs Development and Marketing Agreement for Medications & Nutraceuticals
November 14, 2022
Via
ACCESSWIRE
Halberd Laser Therapy Eliminates over 90% of Multiple Antibiotic Resistant Bacteria in Minutes
October 18, 2022
Via
ACCESSWIRE
Halberd Progresses from Eliminating Top Brain Disease Antigens from CSF To Eradication of Interleukin-6 From Human Blood Serum
October 12, 2022
Via
ACCESSWIRE
Hartman, CEO, and Dr. Felder, CTO of Halberd Corp Featured on The Street Reports Podcast
October 27, 2022
Via
ACCESSWIRE
Halberd Enters Strategic Alliance for Longevity, Alzheimer's Disease, and Cancer Early Detection, Prevention and Treatment
September 27, 2022
Via
ACCESSWIRE
Halberd Enters Strategic Alliance for Longevity, Alzheimer's Disease, and Cancer Early Detection, Prevention and Treatment
September 27, 2022
Jackson Center, Pennsylvania--(Newsfile Corp. - September 27, 2022) - Halberd Corporation (OTC Pink: HALB) entered into a strategic alliance with AI...
Via
Newsfile
Topics
Animal Testing
Artificial Intelligence
Exposures
Animal Testing
Artificial Intelligence
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.